BMO Capital Reaffirms Outperform Rating on Vertex Pharmaceuticals (NASDAQ: VRTX) Amid Strategic Acquisitions and FDA Approval
| 显示全文 |
|
该功能仅适用于授权用户
|
-
债券全称Bank of Montreal
-
注册地国家Canada
-
行业Banks
-
М/S&P/F
*** /*** /***